ECSP15010205A - Nuevos compuestos inhibidores de la fosfodiesterasa del tipo 10a - Google Patents
Nuevos compuestos inhibidores de la fosfodiesterasa del tipo 10aInfo
- Publication number
- ECSP15010205A ECSP15010205A ECIEPI201510205A ECPI201510205A ECSP15010205A EC SP15010205 A ECSP15010205 A EC SP15010205A EC IEPI201510205 A ECIEPI201510205 A EC IEPI201510205A EC PI201510205 A ECPI201510205 A EC PI201510205A EC SP15010205 A ECSP15010205 A EC SP15010205A
- Authority
- EC
- Ecuador
- Prior art keywords
- new type
- inhibiting compounds
- phosphodiesterase inhibiting
- phosphodiesterase
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Addiction (AREA)
- Hospice & Palliative Care (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
VER ANEXO
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261684290P | 2012-08-17 | 2012-08-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
ECSP15010205A true ECSP15010205A (es) | 2016-01-29 |
Family
ID=48986145
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ECIEPI201510205A ECSP15010205A (es) | 2012-08-17 | 2015-03-17 | Nuevos compuestos inhibidores de la fosfodiesterasa del tipo 10a |
Country Status (24)
Country | Link |
---|---|
US (1) | US9464085B2 (es) |
EP (1) | EP2885299B1 (es) |
JP (1) | JP2015524833A (es) |
KR (1) | KR20150042798A (es) |
CN (1) | CN104684912A (es) |
AR (1) | AR092167A1 (es) |
AU (1) | AU2013304043A1 (es) |
BR (1) | BR112015003236A2 (es) |
CA (1) | CA2879485A1 (es) |
CL (1) | CL2015000370A1 (es) |
CR (1) | CR20150082A (es) |
DO (1) | DOP2015000029A (es) |
EC (1) | ECSP15010205A (es) |
HK (1) | HK1211284A1 (es) |
IL (1) | IL236946A0 (es) |
IN (1) | IN2015DN00337A (es) |
MX (1) | MX2015002000A (es) |
PE (1) | PE20151069A1 (es) |
PH (1) | PH12015500348A1 (es) |
RU (1) | RU2015109135A (es) |
SG (1) | SG11201501111YA (es) |
TW (1) | TW201412742A (es) |
UY (1) | UY34980A (es) |
WO (1) | WO2014027078A1 (es) |
Family Cites Families (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030032579A1 (en) | 2001-04-20 | 2003-02-13 | Pfizer Inc. | Therapeutic use of selective PDE10 inhibitors |
US20030166476A1 (en) | 2002-01-31 | 2003-09-04 | Winemiller Mark D. | Lubricating oil compositions with improved friction properties |
EP1651251A4 (en) | 2003-07-31 | 2008-06-18 | Bayer Pharmaceuticals Corp | METHOD FOR THE TREATMENT OF DIABETES AND RELATED DISEASES USING PDE 10A INHIBITORS |
US20090075980A1 (en) | 2003-10-03 | 2009-03-19 | Coley Pharmaceutical Group, Inc. | Pyrazolopyridines and Analogs Thereof |
US20090162286A1 (en) | 2004-06-07 | 2009-06-25 | Pfizer Inc. | Phosphodiesterase 10 Inhibition as Treatment for Obesity-Related and Metabolic Syndrome-Related Conditions |
CA2578996A1 (en) | 2004-09-03 | 2006-03-16 | Memory Pharmaceuticals Corporation | 4-substituted 4, 6-dialkoxy-cinnoline derivatives as phospodiesterase 10 inhibitors for the treatment of psychiatric or neurological syndroms |
WO2007022280A1 (en) | 2005-08-16 | 2007-02-22 | Memory Pharmaceuticals Corporation | Phosphodiesterase 10 inhibitors |
NL2000397C2 (nl) | 2006-01-05 | 2007-10-30 | Pfizer Prod Inc | Bicyclische heteroarylverbindingen als PDE10 inhibitoren. |
WO2007082546A1 (en) | 2006-01-20 | 2007-07-26 | H. Lundbeck A/S | Use of tofisopam as a pde10a inhibitor |
EP1981868A2 (en) | 2006-01-27 | 2008-10-22 | Pfizer Products Inc. | Aminophthalazine derivative compounds |
AU2007217750A1 (en) | 2006-02-21 | 2007-08-30 | Amgen Inc. | Cinnoline derivatives as phosphodiesterase 10 inhibitors |
US20070265270A1 (en) | 2006-02-21 | 2007-11-15 | Hitchcock Stephen A | Cinnoline derivatives as phosphodiesterase 10 inhibitors |
CA2641670A1 (en) | 2006-02-23 | 2007-08-30 | Pfizer Products Inc. | Substituted quinazolines as pde10 inhibitors |
JP2009528365A (ja) | 2006-02-28 | 2009-08-06 | アムゲン インコーポレイティッド | ホスホジエステラーゼ10阻害剤としてのシンノリン及びキナゾリン誘導体 |
US20070265258A1 (en) | 2006-03-06 | 2007-11-15 | Ruiping Liu | Quinazoline derivatives as phosphodiesterase 10 inhibitors |
JP2009529060A (ja) | 2006-03-08 | 2009-08-13 | アムゲン インコーポレイティッド | ホスホジエステラーゼ10阻害剤としてのキノリン及びイソキノリン誘導体 |
TW200817400A (en) * | 2006-05-30 | 2008-04-16 | Elbion Ag | Pyrido [3,2-e] pyrazines, their use as inhibitors of phosphodiesterase 10, and processes for preparing them |
TW200815436A (en) | 2006-05-30 | 2008-04-01 | Elbion Ag | 4-amino-pyrido[3,2-e]pyrazines, their use as inhibitors of phosphodiesterase 10, and processes for preparing them |
WO2008001182A1 (en) | 2006-06-26 | 2008-01-03 | Pfizer Products Inc. | Tricyclic heteroaryl compounds as pde10 inhibitors |
US20080090834A1 (en) | 2006-07-06 | 2008-04-17 | Pfizer Inc | Selective azole pde10a inhibitor compounds |
DK2057153T3 (da) | 2006-07-10 | 2012-10-15 | Lundbeck & Co As H | (3-aryl-piperazin-1-yl)-derivater af 6,7 dialkoxyquinazolin, 6,7- dialkoxyphtalazin og 6,7-dialkoxyisoquinolin |
WO2008020302A2 (en) | 2006-08-17 | 2008-02-21 | Pfizer Products Inc. | Heteroaromatic quinoline-based compounds as phosphodiesterase (pde) inhibitors |
WO2009025823A1 (en) | 2007-08-21 | 2009-02-26 | Amgen Inc. | Phosphodiesterase 10 inhibitors |
WO2009025839A2 (en) | 2007-08-22 | 2009-02-26 | Amgen Inc. | Phosphodiesterase 10 inhibitors |
WO2009029214A1 (en) | 2007-08-23 | 2009-03-05 | Amgen Inc. | Isoquinolone derivatives as phosphodiesterase 10 inhibitors |
TW200918519A (en) | 2007-09-19 | 2009-05-01 | Lundbeck & Co As H | Cyanoisoquinoline |
US20090143361A1 (en) | 2007-11-30 | 2009-06-04 | Elbion Gmbh | Pyrido[3,2-E]Pyrazines, Process For Preparing The Same, And Their Use As Inhibitors Of Phosphodiesterase 10 |
CN101918408A (zh) | 2007-11-30 | 2010-12-15 | 惠氏有限责任公司 | 作为磷酸二酯酶10的抑制剂的芳基和杂芳基稠合的咪唑并[1,5-a]吡嗪 |
WO2009068246A2 (en) | 2007-11-30 | 2009-06-04 | Elbion Gmbh | Methods of treating obesity and metabolic disorders |
EP2227472A1 (en) | 2007-11-30 | 2010-09-15 | Elbion Gmbh | Aryl and heteroaryl fused imidazo (1,5-a) pyrazines as inhibitors of phosphodiesterase 10 |
WO2010054260A1 (en) | 2008-11-07 | 2010-05-14 | Biotie Therapies Gmbh | Imidazo[5,1-c][1,2,4]benzotriazine derivatives as inhibitors of phosphodiesterases |
WO2011008597A1 (en) | 2009-07-14 | 2011-01-20 | Schering Corporation | Dihydroimidazoisoquinoline derivatives useful as pde10 inhibitors |
TW201204727A (en) | 2010-03-10 | 2012-02-01 | Kalypsys Inc | Heterocyclic inhibitors of histamine receptors for the treatment of disease |
DE102010025786A1 (de) | 2010-07-01 | 2012-01-05 | Merck Patent Gmbh | Pyrazolochinoline |
-
2013
- 2013-08-15 UY UY0001034980A patent/UY34980A/es not_active Application Discontinuation
- 2013-08-15 US US13/968,242 patent/US9464085B2/en active Active
- 2013-08-16 MX MX2015002000A patent/MX2015002000A/es unknown
- 2013-08-16 IN IN337DEN2015 patent/IN2015DN00337A/en unknown
- 2013-08-16 SG SG11201501111YA patent/SG11201501111YA/en unknown
- 2013-08-16 RU RU2015109135A patent/RU2015109135A/ru not_active Application Discontinuation
- 2013-08-16 WO PCT/EP2013/067122 patent/WO2014027078A1/en active Application Filing
- 2013-08-16 AR ARP130102932A patent/AR092167A1/es unknown
- 2013-08-16 JP JP2015526996A patent/JP2015524833A/ja not_active Withdrawn
- 2013-08-16 BR BR112015003236A patent/BR112015003236A2/pt not_active IP Right Cessation
- 2013-08-16 TW TW102129554A patent/TW201412742A/zh unknown
- 2013-08-16 CA CA2879485A patent/CA2879485A1/en not_active Abandoned
- 2013-08-16 KR KR20157004416A patent/KR20150042798A/ko not_active Application Discontinuation
- 2013-08-16 CN CN201380043926.2A patent/CN104684912A/zh active Pending
- 2013-08-16 PE PE2015000204A patent/PE20151069A1/es not_active Application Discontinuation
- 2013-08-16 EP EP13750071.6A patent/EP2885299B1/en not_active Not-in-force
- 2013-08-16 AU AU2013304043A patent/AU2013304043A1/en not_active Abandoned
-
2015
- 2015-01-27 IL IL236946A patent/IL236946A0/en unknown
- 2015-02-16 DO DO2015000029A patent/DOP2015000029A/es unknown
- 2015-02-16 CL CL2015000370A patent/CL2015000370A1/es unknown
- 2015-02-17 PH PH12015500348A patent/PH12015500348A1/en unknown
- 2015-02-19 CR CR20150082A patent/CR20150082A/es unknown
- 2015-03-17 EC ECIEPI201510205A patent/ECSP15010205A/es unknown
- 2015-12-04 HK HK15111990.0A patent/HK1211284A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
BR112015003236A2 (pt) | 2017-07-04 |
AR092167A1 (es) | 2015-03-25 |
US9464085B2 (en) | 2016-10-11 |
AU2013304043A1 (en) | 2015-02-05 |
MX2015002000A (es) | 2015-10-09 |
PH12015500348A1 (en) | 2015-04-20 |
JP2015524833A (ja) | 2015-08-27 |
UY34980A (es) | 2014-03-31 |
WO2014027078A1 (en) | 2014-02-20 |
DOP2015000029A (es) | 2015-03-15 |
CL2015000370A1 (es) | 2015-10-02 |
CN104684912A (zh) | 2015-06-03 |
SG11201501111YA (en) | 2015-03-30 |
EP2885299B1 (en) | 2017-04-05 |
IN2015DN00337A (es) | 2015-06-12 |
HK1211284A1 (en) | 2016-05-20 |
TW201412742A (zh) | 2014-04-01 |
RU2015109135A (ru) | 2016-10-10 |
CR20150082A (es) | 2015-05-25 |
KR20150042798A (ko) | 2015-04-21 |
EP2885299A1 (en) | 2015-06-24 |
CA2879485A1 (en) | 2014-02-20 |
PE20151069A1 (es) | 2015-08-29 |
IL236946A0 (en) | 2015-03-31 |
US20140051695A1 (en) | 2014-02-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SMT201700003B (it) | Didropiridoni come inibitori del fattore xia | |
HRP20181429T1 (hr) | Novi derivati benzimidazola kao inhibitori kinaze | |
SMT201700053B (it) | Derivato del cicloalcano | |
CO7030959A2 (es) | Nuevos compuestos inhibidores de la fosfodiesterasa del tipo 10a | |
CO6950479A2 (es) | Compuestos de tetrahidroisoquinolina sustituidos como inhibidores del factor xia | |
CO7010838A2 (es) | Compuestos de imidazopirrolidinona | |
DK2834236T3 (da) | Heterocyclylforbindelser | |
AP2014007836A0 (en) | Apoptosis signal-regulating kinase inhibitor | |
IL238693A0 (en) | Tricyclic benzamidazoles are converted as kinase inhibitors | |
DK3293183T3 (da) | Hæmmerforbindelser | |
CO6990736A2 (es) | Pirrolidina-2-carboxamidas sustituídas | |
UY34654A (es) | Inhibidores de la beta-secretasa | |
DK2692448T3 (da) | Brusehoved | |
HK1210178A1 (en) | Substituted pyridopyrazines as syk inhibitors syk | |
CO7020915A2 (es) | Inhibidores de iap | |
DK2804611T3 (da) | Chitosanafledte forbindelser | |
BR112015003294A2 (pt) | caldeira de armazenamento | |
EP2874632A4 (en) | NEW TRIAZINE COMPOUNDS | |
FI20125972A (fi) | Sovitin | |
DE112013003695A5 (de) | Elektrolyseur | |
ECSP15010205A (es) | Nuevos compuestos inhibidores de la fosfodiesterasa del tipo 10a | |
ES1078189Y (es) | Torreta | |
TH1301007216B (th) | สารประกอบโครมีน | |
ES2390324B8 (es) | Juego de brocas | |
ITMI20122234A1 (it) | Casa del commiato |